Search Results - "GAUR, Rakesh"

Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study by Bradley, Jeffrey D, Prof, Paulus, Rebecca, BS, Komaki, Ritsuko, Prof, Masters, Gregory, MD, Blumenschein, George, Prof, Schild, Steven, Prof, Bogart, Jeffrey, Prof, Hu, Chen, PhD, Forster, Kenneth, PhD, Magliocco, Anthony, Prof, Kavadi, Vivek, MD, Garces, Yolanda I, MD, Narayan, Samir, MD, Iyengar, Puneeth, MD, Robinson, Cliff, MD, Wynn, Raymond B, Prof, Koprowski, Christopher, MD, Meng, Joanne, MD, Beitler, Jonathan, Prof, Gaur, Rakesh, MD, Curran, Walter, Prof, Choy, Hak, Prof

“…Summary Background We aimed to compare overall survival after standard-dose versus high-dose conformal radiotherapy with concurrent chemotherapy and the…”
Get full text

Hematologic Toxicity in RTOG 0418: A Phase 2 Study of Postoperative IMRT for Gynecologic Cancer by Klopp, Ann H., MD, PhD, Moughan, Jennifer, MS, Portelance, Lorraine, MD, Miller, Brigitte E., MD, Salehpour, Mohammad R., PhD, Hildebrandt, Evangeline, CMD, BS, Nuanjing, Jenny, CMD, BS, D'Souza, David, MD, Souhami, Luis, MD, Small, William, MD, Gaur, Rakesh, MD, MPH, Jhingran, Anuja, MD

“…Purpose Intensity modulated radiation therapy (IMRT), compared with conventional 4-field treatment, can reduce the volume of bone marrow irradiated. Pelvic…”
Get full text

Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer by Bear, Harry D, Tang, Gong, Rastogi, Priya, Geyer, Charles E, Robidoux, André, Atkins, James N, Baez-Diaz, Luis, Brufsky, Adam M, Mehta, Rita S, Fehrenbacher, Louis, Young, James A, Senecal, Francis M, Gaur, Rakesh, Margolese, Richard G, Adams, Paul T, Gross, Howard M, Costantino, Joseph P, Swain, Sandra M, Mamounas, Eleftherios P, Wolmark, Norman

“…The addition of bevacizumab to neoadjuvant combination chemotherapy significantly increased the percentage of patients with a pathological complete response…”
Get full text

Influence of Yoga on Cancer-Related Fatigue and on Mediational Relationships Between Changes in Sleep and Cancer-Related Fatigue: A Nationwide, Multicenter Randomized Controlled Trial of Yoga in Cancer Survivors by Lin, Po-Ju, Kleckner, Ian R., Loh, Kah Poh, Inglis, Julia E., Peppone, Luke J., Janelsins, Michelle C., Kamen, Charles S., Heckler, Charles E., Culakova, Eva, Pigeon, Wilfred R., Reddy, Pavan S., Messino, Michael J., Gaur, Rakesh, Mustian, Karen M.

“…Background: Cancer-related fatigue (CRF) often co-occurs with sleep disturbance and is one of the most pervasive toxicities resulting from cancer and its…”
Get full text

Neoadjuvant plus adjuvant bevacizumab in early breast cancer (NSABP B-40 [NRG Oncology]): secondary outcomes of a phase 3, randomised controlled trial by Bear, Harry D, Prof, Tang, Gong, PhD, Rastogi, Priya, MD, Geyer, Charles E, Prof, Liu, Qing, PhD, Robidoux, André, Prof, Baez-Diaz, Luis, MD, Brufsky, Adam M, Prof, Mehta, Rita S, Prof, Fehrenbacher, Louis, MD, Young, James A, MD, Senecal, Francis M, MD, Gaur, Rakesh, MD, Margolese, Richard G, MD, Adams, Paul T, MD, Gross, Howard M, MD, Costantino, Joseph P, Prof, Paik, Soonmyung, Prof, Swain, Sandra M, Prof, Mamounas, Eleftherios P, MD, Wolmark, Norman, Prof

“…Summary Background NSABP B-40 was a 3 × 2 factorial trial testing whether adding capecitabine or gemcitabine to docetaxel followed by doxorubicin plus…”
Get full text

A Phase II Study of Intensity Modulated Radiation Therapy to the Pelvis for Postoperative Patients With Endometrial Carcinoma: Radiation Therapy Oncology Group Trial 0418 by Jhingran, Anuja, MD, Winter, Kathryn, MS, Portelance, Lorraine, MD, Miller, Brigitte, MD, Salehpour, Mohammad, PhD, Gaur, Rakesh, MD, Souhami, Luis, MD, Small, William, MD, Berk, Lawrence, MD, Gaffney, David, MD, PhD

“…Purpose To determine the feasibility of pelvic intensity modulated radiation therapy (IMRT) for patients with endometrial cancer in a multi-institutional…”
Get full text

A Case of De Novo CD5+ Disseminated Intravascular Large B-Cell Lymphoma Presenting as Multiorgan Failure by Gaur, Rakesh, Nanua, Suparna, Kapuria, Devika, Singh, Daulath

“…Intravascular large B-cell lymphoma is an extremely rare extranodal lymphoma that proliferates in the lumen of the blood vessels while sparing the organ…”
Get full text

Postresection CA19-9 and margin status as predictors of recurrence after adjuvant treatment for pancreatic carcinoma: Analysis of NRG oncology RTOG trial 9704 by Regine, William F., MD, Winter, Kathryn, MS, Abrams, Ross A., MD, Safran, Howard, MD, Kessel, Ivan L., MD, Chen, Yuhchyau, MD, PhD, Fugazzi, James A., MD, Donnelly, Eric D., MD, DiPetrillo, Thomas A., MD, Narayan, Samir, MD, Plastaras, John P., MD, Gaur, Rakesh, MD, Delouya, Guila, MD, Suh, John H., MD, Meyer, Joshua E., MD, Haddock, Michael G., MD, Didolkar, Mukund S., MD, Padula, Gilbert D.A., MD, Johnson, David, MD, Hoffman, John P., MD, Crane, Christopher H., MD

“…Abstract Purpose NRG Oncology RTOG 9704 was the first adjuvant trial to validate the prognostic value of postresection CA19-9 levels for survival in patients…”
Get full text

AUGMENT: Lenalidomide/Rituximab vs Placebo/Rituximab in Relapsed or Refractory Indolent Lymphoma by Gaur, Rakesh

“…Objective. To compare the efficacy and safety of lenalidomide in combination with rituximab (known as the R2 regimen) to rituximab plus placebo in patients…”
Get full text

Prescription Drug Benefits and Survival in Myeloma Among Medicare Beneficiaries by Gaur, Rakesh

“…A study which investigates the relationship between prescription drug coverage, receipt of active myeloma therapy, and overall survival (OS) among Medicare…”
Get full text

Treatment of transvestic fetishism with fluoxetine: a case report by Usmani, Mohammad Amir, K Gaur, Rakesh, Ahmad Azmi, Suhail, Gangwar, Sheshank

“…Transvestic fetishism is having a sexual or erotic interest in cross-dressing. This case report describes a 17-year-old male with transvestic fetishism who…”
Get full text

Phase IB/II Randomized Study of FOLFIRINOX Plus Pegylated Recombinant Human Hyaluronidase Versus FOLFIRINOX Alone in Patients With Metastatic Pancreatic Adenocarcinoma: SWOG S1313 by Ramanathan, Ramesh K, McDonough, Shannon L, Philip, Philip A, Hingorani, Sunil R, Lacy, Jill, Kortmansky, Jeremy S, Thumar, Jaykumar, Chiorean, E Gabriela, Shields, Anthony F, Behl, Deepti, Mehan, Paul T, Gaur, Rakesh, Seery, Tara, Guthrie, Katherine A, Hochster, Howard S

“…Pegylated recombinant human hyaluronidase (PEGPH20) degrades hyaluronan (HA) and, in combination with chemotherapy, prolongs survival in preclinical models…”
Get full text

Randomized Phase II Study of Azacitidine Alone or in Combination With Lenalidomide or With Vorinostat in Higher-Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: North American Intergroup Study SWOG S1117 by Sekeres, Mikkael A, Othus, Megan, List, Alan F, Odenike, Olatoyosi, Stone, Richard M, Gore, Steven D, Litzow, Mark R, Buckstein, Rena, Fang, Min, Roulston, Diane, Bloomfield, Clara D, Moseley, Anna, Nazha, Aziz, Zhang, Yanming, Velasco, Mario R, Gaur, Rakesh, Atallah, Ehab, Attar, Eyal C, Cook, Elina K, Cull, Alyssa H, Rauh, Michael J, Appelbaum, Frederick R, Erba, Harry P

“…Purpose Azacitidine is standard, first-line therapy in higher-risk myelodysplastic syndromes (MDS). Whether azacitidine-based combinations with lenalidomide or…”
Get full text

Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer by BEAR, Harry D, GONG TANG, YOUNG, James A, SENECAL, Francis M, GAUR, Rakesh, MARGOLESE, Richard G, ADAMS, Paul T, GROSS, Howard M, COSTANTINO, Joseph P, SWAIN, Sandra M, MAMOUNAS, Eleftherios P, WOLMARK, Norman, RASTOGI, Priya, GEYER, Charles E, ROBIDOUX, André, ATKINS, James N, BAEZ-DIAZ, Luis, BRUFSKY, Adam M, MEHTA, Rita S, FEHRENBACHER, Louis

Get full text

Complete Surgical Excision Is Essential for the Management of Patients With Breast Implant-Associated Anaplastic Large-Cell Lymphoma by Clemens, Mark W, Medeiros, L Jeffrey, Butler, Charles E, Hunt, Kelly K, Fanale, Michelle A, Horwitz, Steven, Weisenburger, Dennis D, Liu, Jun, Morgan, Elizabeth A, Kanagal-Shamanna, Rashmi, Parkash, Vinita, Ning, Jing, Sohani, Aliyah R, Ferry, Judith A, Mehta-Shah, Neha, Dogan, Ahmed, Liu, Hui, Thormann, Nora, Di Napoli, Arianna, DiNapoli, Arianna, Lade, Stephen, Piccolini, Jorge, Reyes, Ruben, Williams, Travis, McCarthy, Colleen M, Hanson, Summer E, Nastoupil, Loretta J, Gaur, Rakesh, Oki, Yasuhiro, Young, Ken H, Miranda, Roberto N

“…Breast implant-associated anaplastic large-cell lymphoma (BI-ALCL) is a rare type of T-cell lymphoma that arises around breast implants. The optimal management…”
Get full text

Effects of aqwise carrier media and brick media as filter materials on performance of biofilm reactor by Singh, Surya Pratap, Sharma, Meena Kumari, Gaur, Rakesh Chandra

“…The present study identifies the effects of two different filter materials, aqwise carrier media (ACM) and brick media (BM), on the performance of an…”
Get full text

Cladribine in the remission induction of adult acute myeloid leukemia: where do we stand? by Qasrawi, Ayman, Bahaj, Waled, Qasrawi, Lien, Abughanimeh, Omar, Foxworth, John, Gaur, Rakesh

“…The combination of cytarabine and an anthracycline has been the standard of care for the induction of remission in acute myeloid leukemia (AML). The response…”
Get full text

Phase 2 trial of dasatinib in target-selected patients with recurrent glioblastoma (RTOG 0627) by Lassman, Andrew B, Pugh, Stephanie L, Gilbert, Mark R, Aldape, Kenneth D, Geinoz, Sandrine, Beumer, Jan H, Christner, Susan M, Komaki, Ritsuko, DeAngelis, Lisa M, Gaur, Rakesh, Youssef, Emad, Wagner, Henry, Won, Minhee, Mehta, Minesh P

“…We conducted a phase II trial to evaluate the efficacy of dasatinib, a multitargeted tyrosine kinase inhibitor, for adults with recurrent glioblastoma (GBM)…”
Get full text

Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study by Dunleavy, Kieron, Fanale, Michelle A, Abramson, Jeremy S, Noy, Ariela, Caimi, Paolo Fabrizio, Pittaluga, Stefania, Parekh, Samir, Lacasce, Ann, Hayslip, John W, Jagadeesh, Deepa, Nagpal, Sunil, Lechowicz, Mary Jo, Gaur, Rakesh, Lucas, Andrea, Melani, Christopher, Roschewski, Mark, Steinberg, Seth M, Jaffe, Elaine S, Kahl, Brad, Friedberg, Jonathan W, Little, Richard F, Bartlett, Nancy L, Wilson, Wyndham H

“…MYC gene rearrangement is present in approximately 10% of aggressive B-cell lymphomas, with half also harbouring a BCL2 gene rearrangement. Multiple…”
Get full text

Effect of Filter Media on Performance of Biofilm Reactor for Treatment of Domestic Wastewater by Singh, Surya Pratap, Sharma, Meena Kumari, Kumar, Chirag, Gaur, Rakesh Chandra

“…Abstract This study is an evaluation of the effects of using filter media on the performance of an integrated settler-based biofilm reactor (ISBR) for onsite…”
Get full text